Filter results by document type and/or working area to find what you're searching for.
Myelodysplastic syndromes (MDS) often go unnoticed when only a complete blood count is performed on the patient. Sysmex X-Class analysers can measure the granularity of leukocytes which is often reduced in MDS. NEUT-X, the measure of neutrophil granularity, is an excellent tool to filter samples suspected of MDS in anaemic patients.
By combining the WDF and WPC channels both the sensitivity and specificity for detecting reactive and malignant cells is optimised. The measurement technology of XN-Series analysers detects the white blood cell functionality and the novel ‘Extended Inflammation Parameters’ let you quantify activated lymphocytes and neutrophils, and the results can be applied once a malignancy has been excluded.
The treatment of immune thrombocytopenia (ITP) can be challenging. The immature platelet count (IPF#) can help, making it easier to monitor the efficacy of the different treatment mechanisms and assessing bleeding risks. This white paper explains how.
A deeper insight about an activation of the immune response of patients can be acquired from newly available diagnostic parameters that support differentiation between inflammation and infection, different pathogenic causes of infection (viral versus bacterial) and different types of immune response: early innate, cellular or humoral immune response.
In daily clinical practice, the treating physician is flooded by the vast amount of available lab parameters and data from which the results relevant to each particular medical case need to be selected. The XE-5000 Case Manager embodies a new concept in diagnostics – one that combines proven Sysmex fluorescence flow cytometry with case-related clinical data.